Whalen Wealth Management Inc. Invests $670,000 in Oscar Health, Inc. (NYSE:OSCR)

Whalen Wealth Management Inc. bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 49,823 shares of the company’s stock, valued at approximately $670,000.

A number of other hedge funds have also added to or reduced their stakes in OSCR. Hennessy Advisors Inc. raised its holdings in shares of Oscar Health by 550.3% in the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the period. Westfield Capital Management Co. LP acquired a new position in Oscar Health during the third quarter worth approximately $27,452,000. JPMorgan Chase & Co. raised its stake in Oscar Health by 68.5% in the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after buying an additional 938,742 shares during the period. Point72 Asset Management L.P. acquired a new stake in shares of Oscar Health in the second quarter valued at approximately $14,716,000. Finally, Soros Fund Management LLC bought a new position in shares of Oscar Health during the 3rd quarter worth approximately $12,726,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Up 4.1 %

Shares of OSCR opened at $16.30 on Thursday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health, Inc. has a 52-week low of $10.84 and a 52-week high of $23.79. The firm has a market cap of $4.03 billion, a price-to-earnings ratio of -271.57, a PEG ratio of 0.63 and a beta of 1.70. The business’s fifty day moving average is $15.17 and its 200-day moving average is $16.81.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm’s revenue was up 68.3% compared to the same quarter last year. During the same period last year, the company posted ($0.29) EPS. Equities analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. UBS Group initiated coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $21.56.

Insider Transactions at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the transaction, the director now directly owns 89,512 shares in the company, valued at $1,526,179.60. This trade represents a 21.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was bought at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the purchase, the insider now owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.